Biotech Blues continuum

Bangalore-based Biocon said on June 29 that it would tie-up with USA's Mylan to supply biosimilars. Mylan will have "exclusive commercialisation rights in the US, Canada, Japan, Australia, New Zealand and in the European Union and countries of the European Free Trade Association" says a report in Business Line.  This bears out what I said … Continue reading Biotech Blues continuum